期刊文献+

辛伐他汀联合依泽替米贝治疗冠心病伴高脂血症的临床疗效及对改善血管内皮功能的影响 被引量:2

下载PDF
导出
摘要 选取我院收治的76例冠心病伴高脂血症患者,依据治疗方法分组,各38例。单一组予以辛伐他汀治疗,联合组予以辛伐他汀+依泽替米贝治疗。统计比较两组患者临床效果、治疗前后血脂指标、血管内皮功能指标变化情况。结果联合组总有效率为94.7%,显著高于单一组的71.1%,差异有统计学意义(P<0.05);治疗后联合组HDL-C、血清NO水平显著高于单一组,LDL-C、TC、TG、ET-1水平低于单一组,差异有统计学意义(P<0.05)。对冠心病伴高脂血症患者予以辛伐他汀与依泽替米贝联合治疗效果显著,可显著改善患者血管内皮功能及血脂水平。
作者 陈长生
机构地区 郑州颐和医院
出处 《现代诊断与治疗》 CAS 2017年第9期1644-1645,共2页 Modern Diagnosis and Treatment
  • 相关文献

参考文献4

二级参考文献39

  • 1刘浩,余金明,陈芳,潘长玉,李觉,胡大一.冠心病患者血脂代谢异常的流行病学研究[J].中国实用内科杂志,2007,27(12):965-967. 被引量:17
  • 2Olsson AG. Statin therapy and reductions in low-density lipoprotein cholesterol : initial clinical data on the potent new statin Rosuvastatin [J]. Am J Cardiol, 2001,87(5A) :33B-36B.
  • 3Blasetto JW, Stein EA, Brown WV, et al. Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholes- terolemic patients and in special population groups [ J ]. Am J Cardi- ol, 2003,91 (5A) :3C-10C.
  • 4Hlatky M. The cost-effectiveness of rosuvastatin therapy JUPITER ( justification for the use of statins al evaluating rosuvastatin) [ J]. J 792-793. in prevention: an intervention tn- Am Coll Cardiol, 2011,57 ( 7 ).
  • 5Capurso C, Solffizzi V, D'Introno A, et al. Beyond coronary artery disease: rosuvastatin in older patients with isehemic systolic heart failure [ J ]. J Am Geriatr Soc, 2008,56 (7) : 1366-1367.
  • 6Nohara R. COSMOS (coronary atherosclemsis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese sub- jects) trial[J]. Nihon Rinsho, 2011,69(Suppl 9) :341-344.
  • 7Scheen AJ. Clinical study of the month: ASTEROID: regression of coronary atheroselemsis with rosuvastatin at a maximal daily, dose of40 mg[J]. Rev Med L(ege, 2006,61(4) :267-272.
  • 8Roth EM, Rosenson RS, Jones PH, et al. Attainment of goal/de- sirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination thera-py : a pooled analysis of controlled studies [ J ]. J Clin Lipi- dol, 2012,6(6) :534-544.
  • 9IuV S, D'iachkov VA, Seleznev EI, et al. Molecular mechanisms of effects of rosuvastatin on systemic oxidative stress and endoge- nous inflammation in patients with atherosclerosis [ J ]. Kardiologi- ia, 2008,48(8) :41-45.
  • 10Yamazaki D, Ishida M, Watanabe H, et al. Comparison of anti-in- flammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and resuvastatin combined with ezetimibe [ J ]. Lipids Health Dis, 2013 ( 12 ) :9.

共引文献58

同被引文献28

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部